• Info
  • Insider Ownership

Insider Trading & Ownership of Samuel Bates Martin

Location
Hampton, NJ
Summary
The estimated net worth of Samuel Bates Martin is at least $341,937 dollars as of 06 Jan 2026. Samuel Bates Martin is the SVP AND CFO of Celldex Therapeutics, Inc. and owns shares of Celldex Therapeutics, Inc. (CLDX) stock worth about $341.9K.
Signature
/s/ Anthony S. Marucci, attorney-in-fact for Samuel Bates Martin
All Insider Reports
All Insider Reports

Notify me when Samuel Bates Martin files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of Samuel Bates Martin

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
CLDX Celldex Therapeutics, Inc. Svp And Cfo $341,937 02 Jan 2026

Insider Transactions Reported by Samuel Bates Martin:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.